Clinical Trial Update: A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 long-term safety study of asoprisnil for uterine fibroids, focusing on safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Leiomyoma | Phase 2 | Status: COMPLETED